Strong Patient Network With a patient registry exceeding 250,000 willing participants across 308 medical conditions, M&B Sciences demonstrates a robust capability to support diverse clinical trial recruitment efforts, presenting opportunities for biotech and pharma clients seeking efficient patient engagement.

Recent Technology Integration The recent integration with Clara Health's platform enhances M&B Sciences' recruiting capabilities, signaling openness to adopting innovative tech solutions that can improve client outcomes and expand service offerings in patient recruitment.

Niche Expertise in Rare Diseases Specializing in rare disease trials and global patient recruitment, M&B Sciences can target niche pharmaceutical companies and research organizations aiming to accelerate recruitment timelines for complex medical conditions.

Market Positioning and Growth Potential As a minority-owned, tech-focused research firm with a growing reputation in clinical trial recruitment, M&B Sciences presents an appealing partnership opportunity for organizations prioritizing diversity and innovative approaches in healthcare research.

Expansion Opportunities Given their successful track record with over 100 global campaigns and recent platform enhancements, there are additional sales prospects in expanding service offerings, including pharmacovigilance studies and market research support for biotech and pharmaceutical clients.